Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Clear all

251 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20024
20032
20045
200513
20065
20076
20085
200916
201010
20114
201216
20134
20149
201510
201610
20178
201813
20199
20209
20214
202210
20234
202412
20257
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed170
Recruiting23
Terminated22
Unknown status15
Withdrawn8
Active, not recruiting6
Not yet recruiting6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)25
University of Toronto8
Novartis Pharmaceuticals6
Duke University5
Indiana University5
Brigham and Women's Hospital4
Massachusetts General Hospital4
National Center for Complementary and Integrative Health (NCCIH)4
Penn State University4
University of Minnesota4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases251
Heart Diseases62
Vascular Diseases37
Hypertension30
Atherosclerosis25
Heart Failure21
Coronary Artery Disease20
Myocardial Ischemia18
Hyperlipidemias15
Inflammation14

Trials

Showing 76 to 100 of 251. Each trial links to its page on Pharma Observatory.

151 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.